Education
About Us
Working with TipRanks
Follow Us
Theralink Technologies (THER)
:THER
Total Valuation
Theralink Technologies has a market cap or net worth of $615.15K. The enterprise value is ―.
Market Cap$615.15K
Enterprise Value―
Share Statistics
Theralink Technologies has 6,151,500,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding6,151,500,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Theralink Technologies’s return on equity (ROE) is 0.81 and return on invested capital (ROIC) is 75.37%.
Return on Equity (ROE)0.81
Return on Assets (ROA)-10.85
Return on Invested Capital (ROIC)75.37%
Return on Capital Employed (ROCE)0.24
Revenue Per Employee37.92K
Profits Per Employee-1.93M
Employee Count16
Asset Turnover0.21
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Theralink Technologies is ―. Theralink Technologies’s PEG ratio is -0.00141.
PE Ratio―
PS Ratio9.12
PB Ratio-0.15
Price to Fair Value-0.15
Price to FCF-0.93
Price to Operating Cash Flow>-0.01
PEG Ratio-0.00141
Income Statement
In the last 12 months, Theralink Technologies had revenue of 606.80K and earned -30.91M in profits. Earnings per share was -0.50.
Revenue606.80K
Gross Profit480.56K
Operating Income-8.98M
Pretax Income-30.91M
Net Income-30.91M
EBITDA-8.73M
Earnings Per Share (EPS)-0.50
Cash Flow
In the last 12 months, operating cash flow was -4.75M and capital expenditures -163.38K, giving a free cash flow of -4.91M billion.
Operating Cash Flow-4.75M
Free Cash Flow-4.91M
Free Cash Flow per Share>-0.01
Dividends & Yields
Theralink Technologies pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-66.52
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)―
Important Dates
Theralink Technologies upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Theralink Technologies as a current ratio of 0.03, with Debt / Equity ratio of -51.85%
Current Ratio0.03
Quick Ratio0.03
Debt to Market Cap3.57
Net Debt to EBITDA-2.15
Interest Coverage Ratio-0.53
Taxes
In the past 12 months, Theralink Technologies has paid 16.71M in taxes.
Income Tax16.71M
Effective Tax Rate-0.54
Enterprise Valuation
Theralink Technologies EV to EBITDA ratio is -2.78, with an EV/FCF ratio of -4.09.
EV to Sales40.05
EV to EBITDA-2.78
EV to Free Cash Flow-4.09
EV to Operating Cash Flow-4.21
Balance Sheet
Theralink Technologies has $998.28K in cash and marketable securities with $19.76M in debt, giving a net cash position of -$18.76M billion.
Cash & Marketable Securities$998.28K
Total Debt$19.76M
Net Cash-$18.76M
Net Cash Per Share>-$0.01
Tangible Book Value Per Share>-$0.01
Margins
Gross margin is 79.20%, with operating margin of -1479.80%, and net profit margin of -5093.56%.
Gross Margin79.20%
Operating Margin-1479.80%
Pretax Margin-5093.56%
Net Profit Margin-5093.56%
EBITDA Margin-1439.10%
EBIT Margin0.00%
Analyst Forecast
The average price target for Theralink Technologies is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―